Colon Pharmaceuticals announced that recently, the controlling shareholder Liu Xinxin released the pledge of 9.167 million shares, accounting for 2.42% of its shares and 0.58% of the company's total share capital; pledged 6.9 million shares, accounting for 1.82% of the company's total share capital, accounting for 0.43% of the company's total share capital, locking in shares for executives to use in their personal capital needs. As of the disclosure date of the announcement, Liu Xinxin and his co-actors have pledged a total of 89.02 million shares, accounting for 22.96% of their shares and 5.60% of the company's total share capital. This pledge will not result in a change in the actual controller and will not adversely affect the company.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.